CIK 0001671584 · Non-accelerated filer<br>Smaller reporting company
Aptevo Therapeutics Inc.
Sign in to watch- Ticker
- APVO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 811567056
- Phone
- 206-838-0500
- Business address
- 2401 4TH AVE., SUITE 1050, SEATTLE, WA, 98121
- 4 Option exercise Chief Medical Officer and SVP acquired 16,269 shares (option exercise)
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G Stake Amended Statement of Ownership
- 4 Option exercise Chief Medical Officer and SVP acquired 27,381 shares (option exercise)
- 4 Option exercise See Remarks acquired 18,136 shares (option exercise)
- 4 Shares withheld for taxes SVP, CFO and Treasurer gave up 7,514 shares (to pay taxes)
- 8-K Event Regulation FD disclosure
- EFFECT Other Notice of Effectiveness
- CORRESP Other Correspondence Between Filers and SEC Staff
- 4 Open-market buy Senior VP, Operations bought 25,000 shares at $2.76 ($69,000)
- CORRESP Other Correspondence Between Filers and SEC Staff
- S-3/A Offering Registration Statement
- CT ORDER Other Confidential Order
- UPLOAD Other SEC-generated Letter
- S-3 Offering Registration Statement
- 10-Q Report Quarterly Report
- 8-K Event Material agreement · Results of operations · Regulation FD disclosure
- 8-K Event Regulation FD disclosure
- 8-K Event Material agreement · Acquisition or sale completed
- 8-K Event Material agreement
Page 32 of 38 · 742 filings